Review Article

[Retracted] Systematic Evaluation of Randomized Clinical Trials of Huangqin Tang in Combination with Mesalazine for Ulcerative Colitis

Table 2

GRADE summary of HQT in the UC randomized controlled trial.

Evaluation of evidence quality
OutcomeNumber of studiesStudy designRisk of biasInconsistencyIndirectnessImprecisionQuality (evidence)Importance of outcome

Cure rate5RCTSeriousaSeriousbNot seriousNot seriousLowCritical
Total effective rate5RCTSeriousaNot seriousNot seriousNot seriousLowCritical
Diarrhea2RCTSeriouscSeriousdNot seriousNot seriousghLowImportant
Abdominal pain2RCTSeriousbSeriousdNot seriousNot seriousghLowImportant
Hematochezia2RCTSeriousbSeriousdNot seriousSeriousghLowImportant
Tenesmus2RCTSeriousbSeriousdNot seriousSeriousghLowImportant
TNF-α3RCTSeriouseSeriousfNot seriousNot seriousLowImportant
IL-103RCTSeriouseNot seriousNot seriousNot seriousLowImportant
IL-62RCTSeriouscNot seriousNot seriousSeriousghLowImportant
IgM2RCTSeriouscNot seriousNot seriousSeriousghLowNot important
IgG2RCTSeriouscNot seriousNot seriousSeriousghLowNot important
IgA2RCTSeriouscNot seriousNot seriousSeriousghLowNot important
Safety3RCTSeriouseNot seriousNot seriousNot seriousLowImportant

aThree studies used the random number table method; it was unclear whether the blind method was used, and random conceals were not reported. bOne study used a significant effect description in which the requirements for clinical symptoms and colonoscopy observation met the cure criteria. cOne study used the random number table method; it was unclear whether the blind method was used, and random conceals were not reported. dThere are operational differences in the clinical symptom score rules. eTwo studies adopted the random number table method, but it was not clear whether the blind method was adopted. fThe experimental data units of one study differed from those of the other studies. gSmall sample size. hLow event rate.